PetMed Express (NASDAQ: PETS) reported Q2 EPS of $0.42, $0.02 better than the analyst estimate of $0.40. Revenue for the quarter came in at $75.4 million versus the consensus estimate of $77.05 million.

For earnings history and earnings-related data on PetMed Express (PETS) click here.